PAVmed (PAVM) Change in Accured Expenses (2015 - 2025)

PAVmed's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at -$175000.0 for Q4 2025.

• On a quarterly basis, Change in Accured Expenses fell 127.6% year-over-year to -$175000.0 in Q4 2025; TTM through Dec 2025 was -$38000.0, a 101.96% decrease from a year earlier, with the FY2025 full-year figure at -$38000.0, up 87.5% from the prior year.
• Change in Accured Expenses eased to -$175000.0 in Q4 2025 per PAVM's latest filing, from -$116000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $2.6 million in Q4 2021 and bottomed at -$1.6 million in Q1 2022.
• The 5-year median for Change in Accured Expenses is $154000.0 (2024), against an average of $265578.9.
• Across the five-year window, Change in Accured Expenses tumbled 970.07% in 2021 and jumped 18066.67% in 2023, its largest moves.
• Year by year, Change in Accured Expenses stood at $2.6 million in 2021, then plunged by 70.57% to $775000.0 in 2022, then soared by 31.48% to $1.0 million in 2023, then sank by 37.78% to $634000.0 in 2024, then slumped by 127.6% to -$175000.0 in 2025.
• Per Business Quant, the three latest PAVM Change in Accured Expenses figures stand at -$175000.0 (Q4 2025), -$116000.0 (Q3 2025), and $493000.0 (Q2 2025).